3 “Strong Buy” Stocks from Wall Street – Week of 10/22

When a stock is rated as a “strong buy,” it typically means that analysts believe the stock has significant potential for growth and that the current price is undervalued. Analysts use a variety of methods to evaluate stocks, including financial analysis, market trends, and company performance. A “strong buy” rating is typically the highest rating an analyst will give to a stock.

Here are three “Strong Buy” stocks from Wall Street –

Rocket Pharmaceuticals, Inc. – SYM: RCKT
Recent Price: $17.83
Price Target: $53.25
Firms with Buy Rating: J.P. Morgan, Cantor Fitzgerald, Needham
Description: Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The company is headquartered in Cranbury, New Jersey.

SPECIAL BROADCAST: The Next Big Transformative Shift is About to Blindside America


Did you see the story in the Wall Street Journal the other day? Only one out of five Americans think their kids will be better off than they are. Frankly, that’s un-American. I don’t care whether you have $5,000 in the bank, or $5 million… Whether you have a blue-collar or a white-collar job… This impacts YOU. In our Exclusive Presentation, we’re giving you a chance to reach out and grab what may be the#1 A.I. Small-Cap Stock Opportunity of the Decade. This could change your financial situation FOREVER.

Click here to learn more.


Taiwan Semiconductor Manufacturing Company Limited – SYM: TSM
Recent Price: $88.60
Price Target: $116.67
Firms with Buy Rating: Barclays, Goldman Sachs, Morgan Stanley
Description: Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides complementary metal oxide silicon wafer fabrication processes to manufacture logic, mixed-signal, radio frequency, and embedded memory semiconductors. The company also offers customer support and engineering services, as well as manufactures masks. Its products are used in high performance computing, smartphone, Internet of things, automotive, and digital consumer electronics. The company was incorporated in 1987 and is headquartered in Hsinchu City, Taiwan.

This Nanotech Could Potentially Disrupt a $3.7 Billion Market

investing insider

A little-known company is developing a new nanotechnology that instantly repels viruses, bacteria, and even the strongest superbugs. It’s being described as ‘the most innovative invention to have a positive impact on the future’. And you have a chance to get in on the company early – before it potentially starts down the path to commercialization.

Find out more about this innovative tech: Access your free report here


AtriCure, Inc. – SYM: ATRC
Recent Price: $34.72
Price Target: $61.86
Firms with Buy Rating: UBS, Needham, Piper Sandler
Description: AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula’s to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.